https://briefpharma.com/synchrony-funds-libairty-expansion-for-copd-care/ 2026-02-19T21:48:11+00:00 https://briefpharma.com/novartis-axes-qeq278-cancer-candidate-on-efficacy-failure/ 2026-02-19T21:47:53+00:00 https://briefpharma.com/jj-builds-next-gen-cell-therapy-plant-in-pennsylvania/ 2026-02-18T22:10:18+00:00 https://briefpharma.com/korsana-launches-with-175m-for-next-gen-alzheimers-drug/ 2026-02-18T22:05:44+00:00 https://briefpharma.com/lilly-pays-100m-upfront-for-csl-clazakizumab-rights/ 2026-02-18T22:04:55+00:00 https://briefpharma.com/gilead-licenses-gh31-for-mtap-deleted-solid-tumours/ 2026-02-17T21:42:35+00:00 https://briefpharma.com/boehringer-halts-inhaled-gene-therapy-for-cystic-fibrosis/ 2026-02-17T21:29:57+00:00 https://briefpharma.com/compass-secures-second-phase-3-victory-for-psilocybin-in-trd/ 2026-02-17T21:25:24+00:00 https://briefpharma.com/lupin-spektus-deal-for-deslaflex-antidepressant-in-canada/ 2026-02-16T22:03:30+00:00 https://briefpharma.com/onos-tirabrutinib-nda-accepted-by-japans-mhlw/ 2026-02-16T21:57:44+00:00 https://briefpharma.com/tozaro-raises-6m-to-advance-smart-polymer-cgt-tools/ 2026-02-16T21:56:52+00:00 https://briefpharma.com/quantx-raises-85m-for-oral-immuno-drugs/ 2026-02-16T21:55:05+00:00 https://briefpharma.com/biosimilars-vs-biologics/ 2026-02-16T17:07:01+00:00 https://briefpharma.com/trimmune-jv-financing-closes-hcw11-006-licensed/ 2026-02-16T16:58:03+00:00 https://briefpharma.com/swiss-life-sciences-fast-2026-start-with-investor-momentum/ 2026-02-16T16:57:50+00:00 https://briefpharma.com/how-biotechs-get-acquired/ 2026-02-16T16:52:35+00:00 https://briefpharma.com/chinas-137-7bn-licensing-surge-set-to-break-records-again/ 2026-02-14T13:19:34+00:00 https://briefpharma.com/agc-expands-global-manufacturing-with-yokohama-hub/ 2026-02-13T11:11:50+00:00 https://briefpharma.com/rottendorf-and-corealis-align-for-seamless-osd-journey/ 2026-02-13T10:56:49+00:00 https://briefpharma.com/asymbio-unveils-full-lifecycle-biopharma-cdmo/ 2026-02-11T22:49:32+00:00 https://briefpharma.com/amply-discovery-partners-keeps-biomed-for-ai-therapeutics/ 2026-02-11T22:40:03+00:00 https://briefpharma.com/fujifilm-expands-uk-biomanufacturing-footprint/ 2026-02-11T22:35:36+00:00 https://briefpharma.com/cannabis-pharmaceutical-report/ 2026-02-10T23:51:52+00:00 https://briefpharma.com/fda-rejects-regenxbio-rgx-121-for-mps-ii/ 2026-02-10T23:01:27+00:00 https://briefpharma.com/nektar-eczema-drug-holds-effects-in-maintenance-phase/ 2026-02-10T22:30:43+00:00 https://briefpharma.com/galux-secures-29m-to-scale-ai-protein-design/ 2026-02-10T21:11:12+00:00 https://briefpharma.com/csl-partners-memo-on-igg-antibody-engineering/ 2026-02-09T22:08:59+00:00 https://briefpharma.com/takeda-deepens-ai-push-with-1-7bn-iambic-pact/ 2026-02-09T22:00:49+00:00 https://briefpharma.com/eli-lilly-inks-8-5bn-oncology-immunology-deal-with-innovent/ 2026-02-09T21:54:05+00:00 https://briefpharma.com/is-biotech-back-four-ipos-raise-nearly-1bn-in-a-week/ 2026-02-08T14:23:06+00:00 https://briefpharma.com/1bn-london-cancer-hub-extension-gets-green-light-in-sutton/ 2026-02-08T14:13:22+00:00 https://briefpharma.com/novartis-starts-work-on-new-global-research-center-in-san-diego/ 2026-02-08T14:08:15+00:00 https://briefpharma.com/epsilon-healthcare-partners-puro-for-european-expansion/ 2026-02-05T22:43:40+00:00 https://briefpharma.com/sobi-snaps-up-arthrosi-in-1-5bn-gout-bet/ 2026-02-05T22:12:51+00:00 https://briefpharma.com/generate-biomedicines-files-for-ai-driven-biotech-ipo/ 2026-02-05T22:08:36+00:00 https://briefpharma.com/cellares-stanford-automate-hsc-manufacturing/ 2026-02-04T19:54:21+00:00 https://briefpharma.com/wave-regains-wve-006-aatd-rights-from-gsk/ 2026-02-04T19:51:22+00:00 https://briefpharma.com/charles-river-shutters-maryland-cdmo-site/ 2026-02-04T19:49:59+00:00 https://briefpharma.com/adragos-pharma-clears-swissmedic-for-sterile-suite/ 2026-02-03T22:36:07+00:00 https://briefpharma.com/vetter-builds-e480m-biologics-fill-finish-plant/ 2026-02-03T22:32:56+00:00 https://briefpharma.com/ema-clears-regulatory-path-for-argenicas-arg-007-stroke-trials/ 2026-02-03T22:28:21+00:00 https://briefpharma.com/india-launches-biopharma-shakti-to-build-biopharma-hub/ 2026-02-02T22:45:07+00:00 https://briefpharma.com/uk-sets-1-5bn-dedicated-life-sciences-rd-budget/ 2026-02-02T22:40:52+00:00 https://briefpharma.com/top-cdmos-for-2026-fujifilm-lonza-samsung-wuxi/ 2026-02-02T22:40:14+00:00 https://briefpharma.com/astrazeneca-pays-1-2bn-for-cspcs-once-monthly-obesity-drugs/ 2026-02-02T22:34:42+00:00 https://briefpharma.com/eylea-biosimilar-gains-uk-eea-launch-dates/ 2026-01-31T10:47:48+00:00 https://briefpharma.com/frontage-grows-early-phase-footprint-globally/ 2026-01-31T10:46:04+00:00 https://briefpharma.com/oracle-unveils-ai-driven-life-sciences-data-platform/ 2026-01-29T23:36:42+00:00 https://briefpharma.com/moderna-teams-up-with-nanexa-to-enhance-injectable-therapy-delivery/ 2026-01-29T23:24:54+00:00 https://briefpharma.com/lillys-retatrutide-smashes-weight-loss-expectations/ 2026-01-29T23:24:31+00:00 https://briefpharma.com/formation-bio-unveils-605m-lynk-deal-for-cns-penetrating-tyk2-inhibitor/ 2026-01-29T23:23:57+00:00 https://briefpharma.com/teva-agrees-to-delist-over-200-fda-orange-book-patents-after-ftc-push/ 2026-01-29T23:23:18+00:00 https://briefpharma.com/adare-cdmo-plans-philadelphia-site-closure-staff-cuts/ 2026-01-29T23:22:51+00:00 https://briefpharma.com/zealand-pharma-and-otr-therapeutics-partner-for-metabolic-therapies/ 2026-01-29T23:22:30+00:00 https://briefpharma.com/mayne-pharma-challenges-cosette-deal-termination/ 2026-01-29T23:21:39+00:00 https://briefpharma.com/sanofi-expands-autoimmune-deal-with-dren-bio/ 2026-01-29T23:20:57+00:00 https://briefpharma.com/sanofis-ms-hopeful-tolebrutinib-hit-by-trial-failure-and-fda-delay/ 2026-01-29T23:20:10+00:00 https://briefpharma.com/sanofi-to-buy-dynavax-in-2-2bn-vaccines-deal/ 2026-01-29T23:19:23+00:00 https://briefpharma.com/royalty-pharma-takes-full-evrysdi-royalty-for-240m/ 2026-01-29T23:18:57+00:00 https://briefpharma.com/trumprx-adds-nine-pharma-giants-to-pricing-scheme/ 2026-01-29T23:18:39+00:00 https://briefpharma.com/insilico-partners-with-servier-on-ai-driven-oncology-discovery/ 2026-01-29T23:18:01+00:00 https://briefpharma.com/nimbus-and-lilly-deepen-tie-up-with-ai-driven-oral-obesity-discovery-deal/ 2026-01-29T23:17:44+00:00 https://briefpharma.com/okyo-pharma-names-robert-dempsey-as-new-ceo/ 2026-01-29T23:17:14+00:00 https://briefpharma.com/sanofi-expands-earendil-ai-bispecifics-deal-to-2-56bn/ 2026-01-29T23:16:49+00:00 https://briefpharma.com/takeda-neuroscience-layoffs-hit-243-ahead-of-trintellix-patent-loss/ 2026-01-29T23:14:13+00:00 https://briefpharma.com/hansa-biopharma-claims-2025-swedenbio-award-on-phase-3-momentum/ 2026-01-29T23:13:38+00:00 https://briefpharma.com/rentschler-biopharma-leadership-transition-to-buecheler/ 2026-01-29T23:12:43+00:00 https://briefpharma.com/novartis-licenses-peptide-rlt-from-zonsen-peplib-biotech-for-50m-upfront/ 2026-01-29T22:23:36+00:00 https://briefpharma.com/rakuten-medical-partners-lotte-biologics-for-photoimmunotherapy-manufacturing/ 2026-01-29T22:23:31+00:00 https://briefpharma.com/interax-and-alveus-launch-small-molecule-metabolic-collaboration/ 2026-01-29T22:23:26+00:00 https://briefpharma.com/ironwood-jumps-on-bullish-2025-26-outlook/ 2026-01-29T22:22:51+00:00 https://briefpharma.com/abbvie-and-gilead-open-2026-with-new-cancer-deals/ 2026-01-29T22:22:46+00:00 https://briefpharma.com/biobeat-raises-50m-series-b-for-cuffless-abpm/ 2026-01-29T22:22:38+00:00 https://briefpharma.com/wegovy-pill-launches-as-first-oral-glp-1-for-weight-loss/ 2026-01-29T22:22:34+00:00 https://briefpharma.com/scenic-biotech-licenses-cell-seq-to-ono-pharma/ 2026-01-29T22:22:13+00:00 https://briefpharma.com/foresee-licenses-mmp-12-inhibitors-to-primevera-for-594m/ 2026-01-29T22:22:07+00:00 https://briefpharma.com/takeda-partners-halozyme-on-vedolizumab-enhanze-sc/ 2026-01-29T22:21:57+00:00 https://briefpharma.com/amgen-disc-medicine-618m-cancer-target-deal/ 2026-01-29T22:21:53+00:00 https://briefpharma.com/jj-signs-mfn-pricing-deal-with-trumprx/ 2026-01-29T22:21:46+00:00 https://briefpharma.com/cytoreason-expands-sanofi-ai-modelling-deal-to-16m/ 2026-01-29T22:21:41+00:00 https://briefpharma.com/merck-eyes-revolution-medicines-in-32bn-oncology-bid/ 2026-01-29T22:21:30+00:00 https://briefpharma.com/eli-lilly-and-nvidia-open-1bn-ai-co-innovation-lab-for-drug-discovery/ 2026-01-29T22:21:24+00:00 https://briefpharma.com/tetrascience-and-thermo-fisher-team-up-to-accelerate-ai-in-biopharma-labs/ 2026-01-29T22:21:18+00:00 https://briefpharma.com/medilink-and-roche-expand-adc-partnership-with-yl201-licensing-deal/ 2026-01-29T22:17:39+00:00 https://briefpharma.com/novartis-licenses-scineuros-alzheimers-antibody-globally/ 2026-01-29T22:17:33+00:00 https://briefpharma.com/nxera-concludes-licensing-and-equity-deal-with-santhera/ 2026-01-29T22:17:27+00:00 https://briefpharma.com/abbvie-embraces-mfn-pricing-with-landmark-100bn-us-investment-commitment/ 2026-01-29T22:13:42+00:00 https://briefpharma.com/chinese-biotechs-set-136bn-out-licensing-record-in-2025/ 2026-01-29T22:13:35+00:00 https://briefpharma.com/samsung-biologics-lays-out-three-pillar-cdmo-growth-plan-at-jpm26/ 2026-01-29T22:13:29+00:00 https://briefpharma.com/thermo-fisher-benefits-from-pharmas-us-manufacturing-shift/ 2026-01-29T22:13:23+00:00 https://briefpharma.com/tiziana-life-sciences-raises-8-8m-for-intranasal-foralumab-development/ 2026-01-29T22:13:18+00:00 https://briefpharma.com/eli-lilly-acquires-ventyx-biosciences-for-1-2bn-to-bolster-inflammation-portfolio/ 2026-01-29T22:13:11+00:00 https://briefpharma.com/nxera-pharmas-daridorexant-meets-phase-3-endpoints-in-south-korea-insomnia-trial/ 2026-01-29T22:13:00+00:00 https://briefpharma.com/arkin-capital-launches-100m-early-stage-biotech-fund/ 2026-01-29T22:12:55+00:00 https://briefpharma.com/novo-nordisk-foundation-pumps-850m-into-european-biotech-innovation/ 2026-01-29T22:12:39+00:00 https://briefpharma.com/irlab-licenses-biomias-cns-compounds-for-isp-screening/ 2026-01-29T22:12:33+00:00 https://briefpharma.com/gsk-expands-immunology-with-2-2bn-rapt-therapeutics-acquisition/ 2026-01-29T22:12:28+00:00 https://briefpharma.com/aax-biotech-and-vascurie-team-up-on-neuro-oncology-antibody-discovery/ 2026-01-29T22:12:22+00:00 https://briefpharma.com/bd-and-ypsomed-expand-high-volume-biologics-delivery-partnership/ 2026-01-29T22:10:14+00:00 https://briefpharma.com/corvus-soquelitinib-phase-1-eczema-data-drives-166-stock-jump/ 2026-01-29T22:10:04+00:00 https://briefpharma.com/ervimmune-lands-e17m-series-a-for-herv-targeted-cancer-vaccine/ 2026-01-29T22:09:27+00:00 https://briefpharma.com/bms-partners-janux-on-850m-solid-tumor-t-cell-engager-program/ 2026-01-29T22:08:07+00:00 https://briefpharma.com/ai-clinical-trials-market-pegged-at-1-5bn-2026-2032/ 2026-01-29T22:07:16+00:00 https://briefpharma.com/corxel-nets-287m-series-d-to-advance-oral-glp-1-obesity-program/ 2026-01-29T22:07:02+00:00 https://briefpharma.com/umass-ials-secures-3-6m-mlsc-grant-for-advanced-research-kit/ 2026-01-29T22:06:55+00:00 https://briefpharma.com/ucb-and-uk-government-launch-major-capital-partnership/ 2026-01-29T22:04:42+00:00 https://briefpharma.com/pharma-layoffs-hit-nine-firms-in-2026-opener/ 2026-01-29T22:04:07+00:00 https://briefpharma.com/st-pharm-secures-56m-us-api-manufacturing-contract/ 2026-01-29T22:03:57+00:00 https://briefpharma.com/boehringer-partners-simcere-on-ibd-bispecific-antibody/ 2026-01-29T22:03:46+00:00 https://briefpharma.com/insilico-partners-qilu-on-ai-driven-cardiometabolic-drugs/ 2026-01-29T22:03:39+00:00 https://briefpharma.com/trexbio-bolsters-immunology-pipeline-with-50m-financing/ 2026-01-29T22:03:28+00:00 https://briefpharma.com/lilly-partners-seamless-on-hearing-loss-gene-editing/ 2026-01-29T22:03:21+00:00 https://briefpharma.com/schmidt-backed-hologen-targets-150m-for-ai-trials/ 2026-01-29T22:03:15+00:00 https://briefpharma.com/mabtech-sai-strategic-immunology-research-tie-up/ 2026-01-29T22:03:08+00:00 https://briefpharma.com/lilly-and-repertoire-strike-2bn-autoimmune-alliance/ 2026-01-29T22:03:02+00:00 https://briefpharma.com/beckman-coulter-partners-with-automata-on-ai-ready-automation/ 2026-01-29T22:02:48+00:00 https://briefpharma.com/pharma-trends-2026/ 2026-01-13T22:32:27+00:00